Delivery Order SPE2DB20D2104-SPE2DB23FS57Z
- Not listed
- This federal contract award is for the delivery of BENICAR 40 MG TABLET 30S (National Drug Code: 4560749067) to the Defense Logistics Agency (DLA). The $7,591.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,868.01 firm-fixed-price delivery order is for the supply of Benicar 40 mg tablets. The contract has an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,066.93 delivery order contract is for the supply of Benicar 40 mg tablets. The contract is a firm-fixed-price delivery order, with an ultimate completion date of September 16, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $25,796.12 delivery order contract is for the supply of Benicar 40 mg tablets. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through May 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to the U.S. government, particularly the Department of...
- This federal contract award, valued at $10,927.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Benicar 40 mg tablets. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Benicar 40 mg tablets. The $17,181.54 firm-fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award, valued at $2,696.77, is for the supply of the medication Benicar 40 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 10, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an...
- This federal contract award is for the delivery of BENICAR 40 MG TABLET 30S, a pharmaceutical product, to the U.S. government. The award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $4,579.79, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as the...
- This federal contract award is for the pharmaceutical product Benicar 40 mg tablets, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $24,809.16 firm-fixed-price delivery order is not designated as a set-aside contract. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB20D2001|SPE2DB24FM39P) from the Defense Logistics Agency (DLA) Troop Support Medical. The $17,501.59 firm fixed-price contract is for the delivery of BENICAR 40 MG TABLET 30S, a prescription medication, with a completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS57ZDelivery Order
This federal contract award is for the delivery of Benicar 40 mg tablets to the Defense Logistics Agency (DLA). The $10,341.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 10, 2023. The award has an ultimate completion date of March 13, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies. This IDC serves as a primary vehicle for the company to deliver critical medications and healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 3/10/23 |